RevitasNOW includes broader analytics of rebate effects with wholesalers and managed markets
In anticipation of its annual users conference (to be held Nov. 5-6 in Philadelphia), Revitas has updated its flagship product, RevitasNow, to include expanded analytics of rebates, which it says will be of particular interest to generics manufacturers and high-volume branded products. A component of RevitasNOW, Revitas Explorer, will have enhanced tools for performing ad-hoc analytics, useful for incentive programs, rebates and related pricing strategies that play out between manufacturers and their trading partners or customers.
The Philadelphia-based company is also strengthening its cloud-based delivery platform, Revitas Flex, to enable better mobile access. The cloud-based platform, besides switching customers of the software from a purchase model to a subscription model, enables users to buy access to the software as their own contract-management needs grow.
“The latest upgrade to the RevitasNOW solution continues our commitment to providing robust, cutting-edge ERD solutions to support emerging growth companies through their development and help them prepare for future growth,” said Al Smith, President and Chief Operating Officer at Revitas. “With deeper insight into revenue management processes through simplified analytics and enhanced mobile access RevitasNOW further optimizes contract, pricing, and compliance management, offering growing companies a flexible, scalable, and cost-effective ERD solution that supports accelerated growth.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.